27th November, 2017

We’re delighted to be launching an exciting new venture between DigitalHealth.London and RYSE Asset Management LLP today. The partnership will see DigitalHealth.London provide screening and evaluation of promising early stage digital health businesses that show the potential to address health and care needs. Using our extensive networks and market knowledge of the health and care sector, we will provide expertise that assesses the feasibility of, and clinical needs met by applicants in order to assist RYSE Asset Management in identifying a small number of potential investments.

You can see the full media release from RYSE here.

Hear from Yinka Makinde, DigitalHealth.London Programme Director about this exciting opportunity. 

We’re looking for companies across a wide spectrum including;

  • Telehealth and care – covering activity/fall monitoring, remote medication management, long term condition monitoring and video consultation
  • mHealth – covering wearables or apps for medical or wellness and fitness
  • Health Analytics – covering genomics, precision medicine or data analytics such as imaging, health data, health status, population health, re-admission rates, bed occupancy or procurement data
  • Digitised health systems – covering patient or provider held digital records or devices and diagnostics

The application process will run until Thursday 18 January 2018. So, if you’re an early stage digital health business in any of these areas, are looking for growth and would like to get involved in this exciting opportunity, apply here.

The application process is designed to be straightforward and easy to complete via an online portal where you can easily upload your responses and relevant materials.

Please find some FAQs below. Do let us know if you have any further queries as you go through the application process and we’ll get back to you as soon as we can. You can contact us by emailing ryse@digitalhealth.london


Frequently Asked Questions:

What is DigitalHealth.London?





DigitalHealth.London is a partnership between three NHS England funded organisations in London – Imperial College Health Partners; Health Innovation Network; and UCLPartners. These are otherwise referred to as Academic Health Science Networks. Plus, MedCity. Together we speed up the scaling and adoption of digital innovations across health and care, by matching innovators with NHS need, and support them to navigate the UK health environment.

Who is RYSE Asset Management?


RYSE Asset Management LLP, established in 2015, is an investment and advisory boutique. Headquartered in London, the experienced team has a long and established track record of building and managing asset management businesses across Europe, delivering bespoke complex solutions to highly discerning institutional and expert private clients across all asset classes. The team’s experience includes public and private investments across real estate, private equity, hedge funds and fund of funds.

The firm’s mission is to provide clients with an unparalleled level of service and expertise that is delivered through a combination of bespoke structuring, innovation, cutting edge solutions and superior risk adjusted performance.  For further information, please visit http://www.ryseam.com/en/.


Why is DigitalHealth.London working with RYSE?

Access to finance is a critical issue for the success of all companies, particularly in healthcare and life sciences. We want to see innovative products and services being delivered to patients and this can only happen with the support of the investment community. By partnering with RYSE, together we are able to help to bring exciting companies active in the DigitalHealth.London ecosystem to potential investment.

Who is eligible to apply?


  1. Early stage companies looking for seed funding (circa £200K – £300K typically).
  2. Committed teams. Single founders considered. Companies with non-healthcare specific teams considered.
  3. Broad therapeutic & technology focus (although companies with offers centered around Robotics should contact us before applying)
  4. Companies with a proposition centered around software with an application in public or private healthcare
  5. Device and Diagnostics based companies will be considered
  6. Established company status preferable
  7. Pre-revenue or revenue generating
  8. No geographical limits (however applicants must agree to work in UK, and a member of the team must be willing to be based in the UK)
What is the nature of the funding being offered through RYSE?


Equity funding is being offered. RYSE will be looking for minority equity stakes in the businesses it invests in, whilst ensuring the founder(s) are still heavily incentivised to build the business. RYSE is prepared to review this on a case by case basis.


Would RYSE consider being part of a syndicate?

Yes potentially, depending on who the other investors were we could invest as part of a syndicate. RYSE is prepared to review this on a case by case basis.

What is the application process?



Interested companies must apply by completing the online application form, with an accompanying 90 second pitch video. (Smartphone quality is fine).

Applications will be reviewed, evaluated and scored by a panel of experts spanning a variety of disciplines including Commercial; Clinical; Operational; Financial.

A shortlist of a minimum of 8 successful applicants will be invited to interview with the RYSE Asset Management team in February 2018.

Applicants should note that the interviews will take place during the week 19 February – 23 February.

Does my company need to be based in London?

We will accept applications from companies based in or outside of London. We will also be delighted to receive applications from companies based outside of the UK. However in this situation, the applicant must agree to work in UK, and a member of the team must be willing to be based in the UK.

How can RYSE help SMEs to perform large scale adoption across the NHS?

With the assistance of its collaboration with DigitalHealth.London it will be able to support teams to achieve large scale adoption across the NHS

The contents of this page are approved and authorised by RYSE Asset Management LLP (Registered in England and Wales no. OC352409. Registered office: 1 Knightsbridge Green, SW1X 7NE London.) which is authorised and regulated by the Financial Conduct Authority.  Ryse Asset Management LLP is subject to regulatory requirements, which can be found at https://register.fca.org.uk/

Submit a Comment

Your email address will not be published. Required fields are marked *